Diane-35 (2mg cyproterone acetate and 0.035mg ethinyl estradiol) - A - Detailing from Skin Therapy Letter


Diane-35 (2mg cyproterone acetate and 0.035mg ethinyl estradiol)







  • Improvements in seborrhea are generally seen after 2 to 3 months.
  • Improvements to acne are generally seen after 3 to 4 months.
  • Numerous studies have proven the efficacy of hormonal therapy in treating acne over 6 or more months of use.
  • Many studies demonstrated the efficacy of Diane-35 in acne over the last 20 years: The Aydinlik trial that included 1161 patients followed for 3 years showed facial acne significantly improved or healed in 72%, 91% and 100% after 6, 12 and 36 months of treatment.
  • In a comparative trial with Minovral (levonorgestrel 150ug/EE 30ug), Diane had a 70% reduction of acne after 6 cycles compared to 35% for the levonorgestrel preparation.
  • Another study comparing Diane-35 and Marvelon (desogestrel 150ug/EE 30ug) over a period of 9 months found acne to improved by 81% with Diane-35 and 63% with Marvelon.
  • Greenwood compared the reduction of lesion between Diane-35 and tetracycline. Results were 74% for Diane-35 and 68% for tetracycline.
  • In the small number of women with severe hyperandrogenism and in whom progress is poor after 3 to 6 months of Diane-35 alone, additional cyproterone acetate of 12.5 to100 mg/day may be given on days 5-14 of the menstrual cycle. This is not commonly done for acne control.

  • Side effects of these higher doses include:
    • fatigue
    • depression
    • reduced libido
    • weight gain
    • breast tenderness
    • worsening of the lipid profile.

Next:   Compliance